# levothyroxine sodium

NDC: 68788-7764
Generic name: levothyroxine sodium
Labeler / Manufacturer: Preferred Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200722

FDA application: NDA021116

## Active ingredients

- LEVOTHYROXINE SODIUM: 175 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-7764"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-7764
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3519c765-2077-4f23-8644-a6242ddbf743
